“Guidelines are not a rulebook; they're a framework for how to think about a particular disease,” says Edward M. Schaeffer, MD, PhD.
In this video, Edward M. Schaeffer, MD, PhD, shares how he utilizes the National Comprehensive Cancer Network’s guidelines for prostate cancer. Schaeffer is chair and Harold Binstein Professor of Urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Adding SBRT to frontline abiraterone shows benefit in oligometastatic CRPC
September 25th 2023The addition of SBRT to upfront abiraterone acetate and prednisone (AAP) reduced the risk of disease progression or death by 65% compared with AAP alone in patients with oligometastatic castration-resistant prostate cancer.
2 Clarke Drive
Cranbury, NJ 08512